Davis
Chief Business Development / M&A Officer
Executive Leadership Team
Morinda
Australia
Biography
Andrew was most recently head of Business Development for Merck’s oncology business and was previously head of Business Development / M&A at Valeant.
Research Interest
Andrew was most recently head of Business Development for Merck’s oncology business and was previously head of Business Development / M&A at Valeant.
